Previous 10 | Next 10 |
home / stock / emhtf / emhtf news
Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics. Introduction Emerald Health Therapeutics ( OTCQX:EMHTF ) only had $3 million cash left at the end of Q2. The company managed to get $25 million from issuing ...
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Cannabis stocks continued to decline last week. Horizons Marijuana Life Sciences Index ETF ( HMLSF ) fell 2.6%, ETFMG Alternative H...
Emerald Health Therapeutics, Inc. (EMHTF) Q2 2019 Earnings Conference Call August 29, 2019, 10:30 AM ET Company Participants Allan Rewak - VP, Communications and Stakeholder Relations Riaz Bandali - CEO Rob Hill - CFO Conference Call Participants Graeme Kreindler - Eight Ca...
VANCOUVER, British Columbia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended June 30, 2019. Full versions of the Company’s unaudited condensed, interim conso...
Emerald Health Therapeutics ( OTCQX:EMHTF ): Q2 GAAP EPS of -C$0.003. More news on: Emerald Health Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has ente...
VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that it will present a corporate overview and be available for 1x1 meetings at the Rodman & Renshaw 21 st Annual Global I...
EMHTF stock is an eye-catcher at present. It’s understandable, considering it’s climbing a whopping 23% at present and currently trading for $2.30 CAD on the TSXV. Emerald Health Therapeutics (TSXV:EMH) (OTCQX:EMHTF) is based in Victoria, Canada. The company’...
VICTORIA, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has provided preliminary, unaudited financial results for the second quarter of 2019 for its BC-based 50%-owned joint venture, Pure Sunfarms (P...
VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives. “With the first 1.1 million square foot (25 acre) green...
News, Short Squeeze, Breakout and More Instantly...
Emerald Health Therapeutics Company Name:
EMHTF Stock Symbol:
OTCMKTS Market:
Emerald Health Therapeutics Website:
Emerald Health Therapeutics Inc (EMHTF) is expected to report for Q3 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to di...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and Skye Bioscience, Inc. (OTCQB: SKYE...